Roivant Sciences GmbH
Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. Roivant's approach is to build entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across the family of Roivant companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. In addition to our biopharmaceutical subsidiaries, Roivant also builds technology-focused Vants focused on improving the process of developing and commercializing medicines. The global headquarters of the biotech group and its subsidiaries are in Basel.